|
|
|
|
|
|
Board of Directors
Nicholas Mitsakos, Chairman
Bay Area investor and entrepreneur focusing on bioscience and communications, co-founded nine
companies that achieved liquidity events through successful IPOs or acquisitions. Investment
Banker at Goldman Sachs and Drexel.
|
|
Richard N. Foster, Ph.D., Director
Managing Partner of Foster Health Partners, LLC. Senior partner and director of McKinsey &
Company. Best-selling author of two books that focus on the relationships between
technological change, innovation and capital formation.
|
|
Frank C. Herringer, Director
Former CEO and current chairman of Transamerica Corporation. Director of Amgen, Inc., the
Charles Schwab Corporation, and Mirapoint, Inc.
|
|
David G. Watumull, President and CEO
More than twenty years experience as a biotechnology industry executive, analyst, and
investment banker. Co-founder of Cardax Pharmaceuticals and co-inventor of initial Cardax
technology. As CEO of Hawaii Biotech, led efforts that raised more than $25 million in
equity financing and $30 million in grant funding.
|
|
Fredric J. Pashkow, M.D., Chief Medical Officer, EVP
Former Vice President U.S. Medical Affairs for the Cardiovascular-Thrombosis Therapeutic
Area at Sanofi-Aventis; Responsible for medicals affairs and clinical trials for drugs
with more than $5 billion in cardiovascular sales. Ten years at the Cleveland Clinic,
former member of the Board of Directors at Hawaii Biotech.
|
|
|
|
|
|
